Reducing levels of toxic RNA with small molecules

ACS Chemical Biology

Volumn 8, Issue 11, 2013, Pages 2528-2537

  Coonrod, Leslie A ^a   Nakamori, Masayuki ^b   Wang, Wenli ^b   Carrell, Samuel ^b   Hilton, Cameron L ^a   Bodner, Micah J ^a   Siboni, Ruth B ^a   Docter, Aaron G ^a   Haley, Michael M ^a   Thornton, Charles A ^b   Berglund, J Andrew ^a  

^a UNIVERSITY OF OREGON   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIDINE; HEPTAMIDINE; MUSCLEBLIND LIKE PROTEIN; PENTAMIDINE; PROPAMIDINE; RNA; RNA BINDING PROTEIN; RNA POLYMERASE II; UNCLASSIFIED DRUG; MOLECULAR LIBRARY;

ACTION POTENTIAL; ALTERNATIVE RNA SPLICING; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAG REPEAT; CELL DEATH; CONTROLLED STUDY; EXON; FEMALE; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; HYDROGEN BOND; HYDROPHOBICITY; IC 50; MOLECULE; MOUSE; MYOTONIA; MYOTONIC DYSTROPHY; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROMOTER REGION; SPLICING DEFECT; TISSUE CULTURE; TOXICITY; ANIMAL; CELL CULTURE; CHEMISTRY; DISEASE MODEL; MALE; METABOLISM; MOLECULAR LIBRARY; PHARMACOLOGY; POLYMERASE CHAIN REACTION;

ANIMALS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FEMALE; MALE; MICE; MYOTONIC DYSTROPHY; PENTAMIDINE; POLYMERASE CHAIN REACTION; RNA; SMALL MOLECULE LIBRARIES;

EID: 84887866065     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb400431f     Document Type: Article

References (59)

1. Cooper, T. A., Wan, L., and Dreyfuss, G. (2009) RNA and disease Cell 136, 777-793
2. Li, Y.-C., Korol, A. B., Fahima, T., Beiles, A., and Nevo, E. (2002) Microsatellites: genomic distribution, putative functions and mutational mechanisms: a review Mol. Ecol. 11, 2453-2465
3. Ranum, L. P. and Cooper, T. A. (2006) RNA-mediated neuromuscular disorders Annu. Rev. Neurosci. 29, 259-277
4. O'Rourke, J. R. and Swanson, M. S. (2009) Mechanisms of RNA-mediated Disease J. Biol. Chem. 284, 7419-7423
5. Shin, J., Charizanis, K., and Swanson, M. S. (2009) Pathogenic RNAs in microsatellite expansion disease Neurosci. Lett. 466, 99-102
6. Cho, D. H. and Tapscott, S. J. (2007) Myotonic dystrophy: Emerging mechanisms for DM1 and DM2 Biochim. Biophys. A, Mol. Basis Dis. 1772, 195-204
7. Harley, H. G., Brook, J. D., Rundle, S. A., Crow, S., Reardon, W., Buckler, A. J., Harper, P. S., Housman, D. E., and Shaw, D. J. (1992) Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy Nature 355, 545-546
8. Mahadevan, M., Tsilfidis, C., Sabourin, L., Shutler, G., Amemiya, C., Jansen, G., Neville, C., Narang, M., Barceló, J., and O'Hoy, K. (1992) Myotonic dystrophy mutation: an unstable CTG repeat in the 3′ untranslated region of the gene Science 255, 1253-1255
9. Liquori, C. L., Ricker, K., Moseley, M. L., Jacobsen, J. F., Kress, W., Naylor, S. L., Day, J. W., and Ranum, L. P. (2001) Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9 Science 293, 864-867
10. Miller, J. W., Urbinati, C. R., Teng-Umnuay, P., Stenberg, M. G., Byrne, B. J., Thornton, C. A., and Swanson, M. S. (2000) Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy EMBO J. 19, 4439-4448
11. Pascual, M., Vicente, M., Monferrer, L., and Artero, R. (2006) The Muscleblind family of proteins: an emerging class of regulators of developmentally programmed alternative splicing Differentiation 74, 65-80
12. Adereth, Y., Dammai, V., Kose, N., Li, R., and Hsu, T. (2005) RNA-dependent integrin alpha3 protein localization regulated by the Muscleblind-like protein MLP1 Nat. Cell Biol. 7, 1240-1247
13. Wang, E. T., Cody, N. A. L., Jog, S., Biancolella, M., Wang, T. T., Treacy, D. J., Luo, S., Schroth, G. P., Housman, D. E., Reddy, S., Lécuyer, E., and Burge, C. B. (2012) Transcriptome-wide regulation of pre-mRNA splicing and mRNA localization by muscleblind proteins Cell 150, 710-724
14. Ho, T. H., Charlet-B, N., Poulos, M. G., Singh, G., Swanson, M. S., and Cooper, T. A. (2004) Muscleblind proteins regulate alternative splicing EMBO J. 23, 3103-3112
15. Hino, S. I., Kondo, S., Sekiya, H., Saito, A., Kanemoto, S., Murakami, T., Chihara, K., Aoki, Y., Nakamori, M., Takahashi, M. P., and Imaizumi, K. (2007) Molecular mechanisms responsible for aberrant splicing of SERCA1 in myotonic dystrophy type 1 Hum. Mol. Genet. 16, 2834-2843
16. Warf, M. B. and Berglund, J. A. (2007) MBNL binds similar RNA structures in the CUG repeats of myotonic dystrophy and its pre-mRNA substrate cardiac troponin T RNA 13, 2238-2251
17. Du, H., Cline, M. S., Osborne, R. J., Tuttle, D. L., Clark, T. A., Donohue, J. P., Hall, M. P., Shiue, L., Swanson, M. S., Thornton, C. A., and Ares, M. (2010) Aberrant alternative splicing and extracellular matrix gene expression in mouse models of myotonic dystrophy Nat. Struct. Mol. Biol. 17, 187-193
18. Sen, S., Talukdar, I., Liu, Y., Tam, J., Reddy, S., and Webster, N. J. G. (2010) Muscleblind-like 1 (Mbnl1) promotes insulin receptor exon 11 inclusion via binding to a downstream evolutionarily conserved intronic enhancer J. Biol. Chem. 285, 25426-25437
19. Gates, D. P., Coonrod, L. A., and Berglund, J. A. (2011) Autoregulated Splicing of muscleblind-like 1 (MBNL1) Pre-mRNA J. Biol. Chem. 286, 34224-34233
20. Mankodi, A., Takahashi, M. P., Jiang, H., Beck, C. L., Bowers, W. J., Moxley, R. T., Cannon, S. C., and Thornton, C. A. (2002) Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy Mol. Cell 10, 35-44
21. Warf, M. B., Nakamori, M., Matthys, C. M., Thornton, C. A., and Berglund, J. A. (2009) Pentamidine reverses the splicing defects associated with myotonic dystrophy Proc. Natl. Acad. Sci. U.S.A. 106, 18551-18556
22. Arambula, J. F., Ramisetty, S. R., Baranger, A. M., and Zimmerman, S. C. (2009) A simple ligand that selectively targets CUG trinucleotide repeats and inhibits MBNL protein binding Proc. Natl. Acad. Sci. U.S.A. 106, 16068-16073
23. Wong, C.-H., Fu, Y., Ramisetty, S. R., Baranger, A. M., and Zimmerman, S. C. (2011) Selective inhibition of MBNL1-CCUG interaction by small molecules toward potential therapeutic agents for myotonic dystrophy type 2 (DM2) Nucleic Acids Res. 39, 8881-8890
24. Parkesh, R., Childs-Disney, J. L., Nakamori, M., Kumar, A., Wang, E., Wang, T., Hoskins, J., Tran, T., Housman, D., Thornton, C. A., and Disney, M. D. (2012) Design of a bioactive small molecule that targets the myotonic dystrophy type 1 RNA via an RNA motif-ligand database and chemical similarity searching J. Am. Chem. Soc. 134, 4731-4742
25. Lee, M. M., Pushechnikov, A., and Disney, M. D. (2009) Rational and modular design of potent ligands targeting the RNA that causes myotonic dystrophy 2 ACS Chem. Biol. 4, 345-355
26. Pushechnikov, A., Lee, M. M., Childs-Disney, J. L., Sobczak, K., French, J. M., Thornton, C. A., and Disney, M. D. (2009) Rational design of ligands targeting triplet repeating transcripts that cause RNA dominant disease: application to myotonic muscular dystrophy type 1 and spinocerebellar ataxia type 3 J. Am. Chem. Soc. 131, 9767-9779
27. Childs-Disney, J. L., Hoskins, J., Rzuczek, S. G., Thornton, C. A., and Disney, M. D. (2012) Rationally designed small molecules targeting the RNA that causes myotonic dystrophy type 1 are potently bioactive ACS Chem. Biol. 7, 856-862
28. Gareiss, P. C., Sobczak, K., McNaughton, B. R., Palde, P. B., Thornton, C. A., and Miller, B. L. (2008) Dynamic combinatorial selection of molecules capable of inhibiting the (CUG) repeat RNA-MBNL1 interaction in vitro: discovery of lead compounds targeting myotonic dystrophy (DM1) J. Am. Chem. Soc. 130, 16254-16261
29. Garcia-Lopez, A., Llamusí, B., Orzáez, M., Pérez-Payá, E., and Artero, R. D. (2011) In vivo discovery of a peptide that prevents CUG-RNA hairpin formation and reverses RNA toxicity in myotonic dystrophy models Proc. Natl. Acad. Sci. U.S.A. 108, 11866-11871
30. Ofori, L. O., Hoskins, J., Nakamori, M., Thornton, C. A., and Miller, B. L. (2012) From dynamic combinatorial "hit" to lead: in vitro and in vivo activity of compounds targeting the pathogenic RNAs that cause myotonic dystrophy Nucleic Acids Res. 40, 6380-6390
31. Wheeler, T. M., Sobczak, K., Lueck, J. D., Osborne, R. J., Lin, X., Dirksen, R. T., and Thornton, C. A. (2009) Reversal of RNA dominance by displacement of protein sequestered on triplet repeat RNA Science 325, 336-339
32. Phylactou, L. A., Darrah, C., and Wood, M. J. (1998) Ribozyme-mediated trans-splicing of a trinucleotide repeat Nat. Genet. 18, 378-381
33. Langlois, M.-A., Lee, N. S., Rossi, J. J., and Puymirat, J. (2003) Hammerhead ribozyme-mediated destruction of nuclear foci in myotonic dystrophy myoblasts Mol. Ther. 7, 670-680
34. Chen, H. Y., Kathirvel, P., Yee, W. C., and Lai, P. S. (2009) Correction of dystrophia myotonica type 1 pre-mRNA transcripts by artificial trans-splicing Gene Ther. 16, 211-217
35. Furling, D., Doucet, G., Langlois, M.-A., Timchenko, L., Belanger, E., Cossette, L., and Puymirat, J. (2003) Viral vector producing antisense RNA restores myotonic dystrophy myoblast functions Gene Ther. 10, 795-802
36. Langlois, M.-A., Boniface, C., Wang, G., Alluin, J., Salvaterra, P. M., Puymirat, J., Rossi, J. J., and Lee, N. S. (2005) Cytoplasmic and nuclear retained DMPK mRNAs are targets for RNA interference in myotonic dystrophy cells J. Biol. Chem. 280, 16949-16954
37. Mulders, S. A. M., van den Broek, W. J. A. A., Wheeler, T. M., Croes, H. J. E., van Kuik-Romeijn, P., de Kimpe, S. J., Furling, D., Platenburg, G. J., Gourdon, G., Thornton, C. A., Wieringa, B., and Wansink, D. G. (2009) Triplet-repeat oligonucleotide-mediated reversal of RNA toxicity in myotonic dystrophy Proc. Natl. Acad. Sci. U.S.A. 106, 13915-13920
38. Lee, J. E., Bennett, C. F., and Cooper, T. A. (2012) RNase H-mediated degradation of toxic RNA in myotonic dystrophy type 1 Proc. Natl. Acad. Sci. U.S.A. 109, 4221-4226
39. Wheeler, T. M., Leger, A. J., Pandey, S. K., MacLeod, A. R., Nakamori, M., Cheng, S. H., Wentworth, B. M., Bennett, C. F., and Thornton, C. A. (2012) Targeting nuclear RNA for in vivo correction of myotonic dystrophy Nature 488, 111-115
40. Parsons, M. A., Sinden, R. R., and Izban, M. G. (1998) Transcriptional properties of RNA polymerase II within triplet repeat-containing DNA from the human myotonic dystrophy and fragile X loci J. Biol. Chem. 273, 26998-27008
41. Salinas-Rios, V., Belotserkovskii, B. P., and Hanawalt, P. C. (2011) DNA slip-outs cause RNA polymerase II arrest in vitro: potential implications for genetic instability Nucleic Acids Res. 39, 7444-7454
42. Wilson, W. D., Ratmeyer, L., Zhao, M., Strekowski, L., and Boykin, D. (1993) The search for structure-specific nucleic acid-interactive drugs: effects of compound structure on RNA versus DNA interaction strength Biochemistry 32, 4098-4104
43. Tao, B., Huang, T. L., Zhang, Q., Jackson, L., Queener, S. F., and Donkor, I. O. (1999) Synthesis and anti-Pneumocystis carinii activity of conformationally restricted analogues of pentamidine Eur. J. Med. Chem. 34, 531-538
44. Edwards, K. J., Jenkins, T. C., and Neidle, S. (1992) Crystal structure of a pentamidine-oligonucleotide complex: implications for DNA-binding properties Biochemistry 31, 7104-7109
45. Grant, L., Sun, J., Xu, H., Subramony, S. H., Chaires, J. B., and Hebert, M. D. (2006) Rational selection of small molecules that increase transcription through the GAA repeats found in Friedreich's ataxia FEBS Lett. 580, 5399-5405
46. Liu, C.-R., Chang, C.-R., Chern, Y., Wang, T.-H., Hsieh, W.-C., Shen, W.-C., Chang, C.-Y., Chu, I.-C., Deng, N., Cohen, S. N., and Cheng, T.-H. (2012) Spt4 is selectively required for transcription of extended trinucleotide repeats Cell 148, 690-701
47. Luck, G., Zimmer, C., and Schweizer, D. (1988) DNA binding studies of the nonintercalative ligand pentamidine: dA*dT basepair preference Studia Biophys. 125, 107-119
48. Jenkins, T. C. and Lane, A. N. (1997) AT selectivity and DNA minor groove binding: modelling, NMR and structural studies of the interactions of propamidine and pentamidine with d(CGCGAATTCGCG)2 Biochim. Biophys. Acta, Gene Struct. Expression 1350, 189-204
49. Bailly, C., Perrine, D., Lancelot, J. C., Saturnino, C., Robba, M., and Waring, M. J. (1997) Sequence-selective binding to DNA of bis(amidinophenoxy) alkanes related to propamidine and pentamidine Biochem. J. 323 (Pt 1) 23-31
50. Vázquez, O., Sánchez, M. I., Martínez-Costas, J., Vázquez, M. E., and Mascareñas, J. L. (2010) Bis-4- aminobenzamidines: Versatile, Fluorogenic A/T-Selective dsDNA Binders Org. Lett. 12, 216-219
51. Jog, S. P., Paul, S., Dansithong, W., Tring, S., Comai, L., and Reddy, S. (2012) RNA splicing is responsive to MBNL1 dose PLoS One 7, e48825
52. Zhang, Y., Bell, A., Perlman, P. S., and Leibowitz, M. J. (2000) Pentamidine inhibits mitochondrial intron splicing and translation in Saccharomyces cerevisiae RNA 6, 937-951
53. Sun, T. and Zhang, Y. (2008) Pentamidine binds to tRNA through non-specific hydrophobic interactions and inhibits aminoacylation and translation Nucleic Acids Res. 36, 1654-1664
54. Warf, M. B., Diegel, J. V., Hippel, von, P. H., and Berglund, J. A. (2009) The protein factors MBNL1 and U2AF65 bind alternative RNA structures to regulate splicing Proc. Natl. Acad. Sci. U.S.A. 106, 9203-9208
55. Lipinski, C. A., Lombardo, F., Dominy, B. W., and Feeney, P. J. (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Adv. Drug Delivery Rev. 46, 3-26
56. Mankodi, A., Logigian, E., Callahan, L., McClain, C., White, R., Henderson, D., Krym, M., and Thornton, C. A. (2000) Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat Science 289, 1769-1773
57. Kimura, T. (2005) Altered mRNA splicing of the skeletal muscle ryanodine receptor and sarcoplasmic/endoplasmic reticulum Ca2+-ATPase in myotonic dystrophy type 1 Hum. Mol. Genet. 14, 2189-2200
58. Tidwell, R. R., Jones, S. K., Geratz, J. D., Ohemeng, K. A., Cory, M., and Hall, J. E. (1990) Analogues of 1,5-bis(4-amidinophenoxy)pentane (pentamidine) in the treatment of experimental Pneumocystis carinii pneumonia J. Med. Chem. 33, 1252-1257
59. Kanadia, R. N. (2003) A muscleblind knockout model for myotonic dystrophy Science 302, 1978-1980